INmune Bio, a late-stage biotech company, announced a $4.5 million registered direct offering of 3 million common shares and a concurrent private placement of warrants to purchase an additional 3 million shares. The warrants have an exercise price of $1.65 and a 5.5-year term, exercisable after six months. Proceeds will support working capital and general corporate needs as the company advances its inflammation and immunology treatments, including late-stage platforms CORDStrom™ and XPro1595™. The offering is expected to close around October 29, 2026, subject to customary conditions.
INmune Bio's recent $4.5 million registered direct offering and private placement provide context for readers following biotech developments. For readers following the health sector, here is Pluang's market snapshot as of Oct 28, 2026 19:11 WIB: Of 150 priced US health stocks, 42 rose and 97 fell. GE HealthCare Technologies Inc. (GEHC) gained 8.28% to USD 77.00, contrasting with BioNano Genomics Inc. (BNGO) which dropped 8.20% to USD 1.12 with a typical hold time of 51 days on Pluang, while Aurora Cannabis Inc. (ACB) rose 6.99% to USD 4.44 with a shorter typical hold time of 26 days.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
